Augmentation strategies in patients with refractory depression

Depression and Anxiety

Volumn 4, Issue 4, 1996, Pages 169-181

  Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

augmentation; combination therapy; lithium; refractory depression; resistant depression; selective serotonin reuptake inhibitors; thyroid hormone; tricyclic antidepressants

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; LIOTHYRONINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PINDOLOL; PSYCHOSTIMULANT AGENT; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS;

EID: 0030429499     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1996)4:4<169::AID-DA3>3.0.CO;2-A     Document Type: Article

References (103)

1. Amsterdam JD, Berwish NJ (1989) High-dose tranylcypromine therapy for refractory depression. Pharmacopsychiatry 22:21-25.
2. Anfinson TJ, Boswell E, Nemeroff CB (1997) Psychiatric manifestations of endocrine disorders. In Yudofsky S, Hales R (eds): Textbook of Neuropsychiatry, 2nd ed. Washington, DC: American Psychiatric Association Press, Inc. (in press).
3. Artigas F (1995) Pindolol, 5-hydroxytryptamine, and antidepressant augmentation (letter). Arch Gen Psychiatry 52:969-971.
4. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251.
5. Austin MPV, Souza FGM, Goodwin GM (1991) Lithium augmentation in antidepressant-resistant patients: A quantitative analysis. Br J Psychiatry 159:510-514.
6. Banki CM (1977) Ccrebrospinal fluid amine metabolites after combined amitriptyline triiodythronine treatment of depressed women. Eur J Clin Pharmacol 11:311-315.
7. Beasley CM Jr, Bosomworth JC, Wernicke JF (1990a) Fluoxerine: Relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacol Bull 26:18-24.
8. Beasley CM Jr, Sayler ME, Cunningham GE, Weiss AM, Masica DN (1990b) Fluoxetine in tricyclic-refractory major depressive disorder. J Affect Disord 20:193-200.
9. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222.
10. Blier P, de Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7(Suppl):24S-35S.
11. Boyer WF, Feighner JP (1994) Clinical significance of early nonresponse in depressed patients. Depression 2:32-35.
12. Boyer W, Nemeroff CB (1997) Somatic approaches to treatment-resistant depression. In Doeherty J (ed): Inpatient Psychiatry in the 90s. Washington, DC: APA Press (in press).
13. Brown WA, Harrison W (1995) Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 56:30-34.
14. Cole PA, Bostwick JM, Fajtova VT (1993) Thyrotoxicosis in a depressed patient on L-triiodothytonine. Psychosomatics 34:539-540.
15. 4-replaced thyroid patients. J Clin Psychiatry 53:16-18.
16. Corrigan FM (1992) Sodium valproate augmentation of fluoxetine or fluvoxamine effects. Biol Psychiatry 31:1178-1179.
17. Delgado PL, Price LH, Charney DS, Heninger GR (1988) Efficacy of fluvoxamine in treatment-refractory depression. J Affect Disord 15:55-60.
18. de Montigny C (1994) Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 9(Suppl 2):31-35.
19. de Montigny C, Cournoyer G, Morissette R, Langlois R, Caillé G (1983) Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry 40:1327-1334.
20. Depression Guideline Panel (1993) Depression in Primary Care, Volume 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication no. 93-0551, April 1993.
21. Dinan TG (1993) Lithium augmentation in sertraline-resistant depression: A preliminary dose-response study. Acta Psychiatr Scand 88:300-301.
22. Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80:97-100.
23. Earle BV (1970) Thyroid hormone the tricyclic antidepressants in resistant depressions. Am J Psychiatry 126:143-145.
24. Fabre LF (1990) Buspirone in the management of major depression: A placebo-controlled comparison. J Clin Psychiatry 51(Suppl 9):55-61.
25. Fava M, Rosenbaum JF, Cohen L, Reiter S, McCarthy M, Steingard R, Clancy K (1992) High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine. J Affect Disord 25:229-234.
26. Fava M, Rosenbaurn JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A double-blind, controlled study. Am J Psychiatry 151:1372-1374.
27. Flint AJ, Rifat SL (1994) A prospective study of lithium augmentation an antidepressant-resistant geriatric depression. J Clin Psychopharmacol 14:353-356.
28. Fontaine R, Ontiveros A, Elie R, Vézina M (1991) Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression. Biol Psychiatry 29:946-948.
29. Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N (1987) Failure of T3 to potentiate tricyclic antidepressant response. J Affect Disord 13:267-272.
30. Goodwin FK, Prange AJ Jr, Post RM, Muscettola G, Lipton MA (1982) Potentiation of patients effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry 139:34-38.
31. Green AI, Austin CP (1993) Psychopathology of pancreatic cancer: A psychobiologic probe. Psychosomatics 34:208-221.
32. Gupta S, Ghaly N, Dewan M (1992) Augmenting fluoxetine with dextroamphetamine to treat refractory depression. Hosp Community Psychiatry 43:281-283.
33. Haggerty JJ Jr, Garbutt JC, Evans DL, Golden RN, Pedersen C, Simon JS, Nemeroff CB (1990) Subclinical hypothyroidism: A review of neuropsychiatric aspects. Int J Psychiatry Med 20:193-208.
34. Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40:1335-1342.
35. Henry JA, Hale AS (1994) Selective serotonin reuptake inhibitors: Unsuccessful treatment may be related to nonresponse or noncompliance (letter, comment). BMJ 309:1083.
36. Hoencamp E, Haffmans PMJ, Dijken WA, Hoogduin CAL, Nolen WA, van Dyck R (1994) Brofaromine versus lithium addition to maprotiline: A double-blind study in maprotiline-refractory depressed outpatients. J Affect Disord 30:219-227.
37. Holroyd S, Cohen MJ (1990) Treatment of hyperprolactinemia in major depression (letter). Am J Psychiatry 147:810.
38. Howland RH (1993) Thyroid dysfunction in refractory depression: Implications for pathophysiology and treatment. J Clin Psychiatry 54:47-54.
39. Jacobsen FM (1991) Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 52:217-220.
40. Joffe RT (1988) Triiodothyronine potentiation of the antidepressive effect of phenelzine. J Clin Psychiatry 49:409-410.
41. Joffe RT (1992) Triiodothyronine potentiation of fluoxetine in depressed patients. Can J Psychiatry 37:48-50.
42. Joffe RT, Levitt AJ (1992) Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 17:215-221.
43. Joffe RT, Levitt AJ (1995) Antidepressant failure: Augmentation or substitution? J Psychiatry Neurosci 20:7-9.
44. Joffe RT, Schuller DR (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 54:269-271.
45. Joffe RT, Singer W (1990) A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 32:241-251.
46. Joffe RT, Levitt AJ, Bagby RM, MacDonald C, Singer W (1993a) Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic nonresponders. Br J Psychiatry 163:574-578.
47. Joffe RT, Singer W, Levitt AJ, MacDonald C (1993b) A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50:387-393.
48. Joffe RT, Levitt AJ, Sokolov STH, Young LT (1996) Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 57:114-115.
49. Kaplan R (1992) Obstructive sleep apnoea and depression: Diagnostic and treatment implications. Aust N Z J Psychiatry 26:586-591.
50. Katon W, Von Korff M, Lin E, Bush T, Ormel J (1992) Adequacy and duration of antidepressant treatment in primary care. Med Care 30:67-76.
51. Katona CLE, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, Burns RA, Robertson MM (1995) Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 166:80-86.
52. King DE, Finestone DH, Peden JG (1994) Combination antidepressant therapy in primary care. Arch Fam Med 3:1088-1092.
53. Kojima H, Terao T, Yoshimura R (1993) Seroronin syndrome during clomipramine and lithium treatment (letter). Am J Psychiatry 150:1897.
54. Kreider MS, Bushnell WD, Oakes R, Wheadon DE (1995) A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. J Clin Psychiatry 56:142-145.
55. Lin EHB, Von Korff M, Katon W, Bush T, Simon GE, Walker E, Robinson P (1995) The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 33:67-74.
56. Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients. Pharmacopsychiatry 27(Suppl):51-53.
57. MacEwan GW, Remick RA (1988) Treatment-resistant depression: A clinical perspective. Can J Psychiatry 33:788-792.
58. Mann JJ, Aarons SF, Wilner PJ, Keilp JG, Sweeney JA, Pearlstein T, Frances AJ, Kocsis JH, Brown RP (1989) A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl: A selective monoamine oxidase inhibitor. Arch Gen Psychiatry 46:45-50.
59. McGrath PJ, Stewart JW, Nunes EV, Ocepek-Welikson K, Rabkin JG, Quitkin FM, Klein DF (1993) A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry 150:118-123.
60. Muly EC, McDonald W, Steffens D, Book S (1993) Serotonin syndrome produced by a combination of fluoxetine and lithium (letter). Am J Psychiatry 150:1565.
61. Nelsen MR, Dunner DL (1993) Treatment resistance in unipolar depression and other disorders: Diagnostic concerns and treatment possibilities. Psychiatr Clin North Am 16:541-566.
62. Nelsen MR, Dunner DL (1995) Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res 29:43-50.
63. Nelson JC, Mazure CM (1996) Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 143:363-366.
64. Nelson JC, Mazure CM, Bowers MB Jr, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48:303-307.
65. Nelson JC, Mazure CM, Jatlow PI (1994) Characteristics of desipramine-refractory depression. J Clin Psychiatry 55:12-19.
66. Nemeroff CB (1991) Augmentation regimens for depression. J Clin Psychiatry 52(Suppl 5):21-27.
67. Nemeroff CB, DeVane CL, Pollock BG (1996) Newer antidepressants and the cytochrome P450 system. AmJ Psychiatry 153:311-320.
68. Nierenberg AA (1990) Methodological problems in treatment-resistant depression research. Psychopharmacol Bull 26:461-464
69. Nierenberg AA (1991) Treatment choice after one antidepressant fails: A survey of northeastern psychiatrists. J Clin Psychiatry 52:383-385.
70. Nierenberg AA, Price LH, Charney DS, Heninger GR (1990) After lithium augmentation: A retrospective follow-up of patients with antidepressant-refractory depression. J Affect Disord 18:167-175.
71. Nierenberg AA, Cole JO, Glass L (1992) Possible trazodone potentiation of fluoxetine: A case series. J Clin Psychiatry 53:83-85.
72. Nierenberg AA, Feighner JP, Rudolph R, Cole JO, Sullivan J (1994) Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 14:419-423.
73. Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M (1995) Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152:1500-1503.
74. Ogura C, Okuma T, Uchida Y, Imai S, Yogi H, Sumami Y (1974) Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states. Folia Psychiatr Neurol Jpn 28:179-186.
75. Orrell M, Collins E, Shergill S, Katona C (1995) Management of depression in the elderly by general practitioners. I. Use of antidepressants. Fam Pract 12:5-11.
76. Patten SB, Love EJ (1994) Drug-induced depression: Incidence, avoidance, and management. Drug Saf 10:203-219.
77. Price LH, Conwell Y, Nelson JC (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140:318-322.
78. Price LH, Charney DS, Delgado PL, Heninger GR (1990) Fenfluramine augmentation in tricyclic-refractory depression. J Clin Psychopharmacol 10:312-317.
79. Prudic J, Sackeim HA, Devanand DP (1990) Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31:287-296.
80. Ribkin JG, Rabkin R, Wagner G (1994) Effects of fluoxetine on mood and immune status in depressed patients with HIV illness. J Clin Psychiatry 55-92-97.
81. Rodin G, Craven J, Littlefield C (1991) Depression in the Medically Ill: An Integrated Approach. New York: Brunner/Mazel, Inc. pp 130-134, 235-263.
82. Russ MJ, Ackerman SH (1989) Antidepressant treatment response in depressed hypothyroid patients. Hosp Community Psychiatry 40:954-956.
83. Rybakowski J, Matkowski K (1992) Adding lithium to antidepressant therapy: Factors related to therapeutic potentiation. Eur Neuropsychopharmacol 2:161-165.
84. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10:96-104.
85. Schopf J, Baumann P, Lemarchand T, Rey M (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: Results of a placebo-controlled double-blind study. Pharmacopsychiatry 22:183-187.
86. Schweizer E, Rickets K, Amsterdam JD, Fox I, Puzzuoli G, Weise C (1990) What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry 51:8-11.
87. Stassen HH, Angst J, Delini-Stula A (1994) Severity at baseline and onset of improvement in depression: Meta-analysis of imipramine and moclobemide versus placebo. Eur J Psychiatry 9:129-136.
88. Stein G, Bernadt M (1993) Lithium augmentation therapy in tricyclic-resistant depression: A controlled trial using lithium in low and normal doses. Br J Psychiatry 162:634-640.
89. Stock AJ, Kofoed L (1994) Therapeutic interchange of fluoxetine and sertraline. Experience in the clinical setting. Am J Hosp Pharm 51:2279-2281.
90. Sunderland T, Cohen RM, Molchan S, Lawlor BA, Mellow AM, Newhouse PA, Tariot PN, Mueller RA, Murphy DL (1994) High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 51:607-615.
91. Targum SD, Greenberg RD, Harmon RL, Kessler K, Salerian AJ, Fram DH (1984) Thyroid hormone and the TRH stimulation in refractory depression. J Clin Psychiatry 45:345-346.
92. Thase ME, Rush AJ (1995) In Bloom SE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: American College of Neuropsychopharmacology, Raven Press Ltd, pp 1081-1097.
93. Thase ME, Kupfer DJ, Jarrett DB (1989a) Treatment of imipramme-resistant recurrent depression. I. An open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry 50:385-388.
94. Thase ME, Kupfer DJ, Frank E, Jarrett DB (1989b) Treatment of imipramine-resistant recurrent depression. II. An open clinical trial of lithium augmentation. J Clin Psychiatry 50:413-417.
95. Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ (1992) Treatment of imipramine-resistant recurrent depression, III. Efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 53:5-11.
96. Thase ME, Rush AJ, Kasper S, Nemcroff CB (1995) Tricyclics and newer antidepressant medications: Treatment options for treatment-resistant depression. Depression 2:152-168.
97. Tsutsui S, Yamazaki Y, Namba T, Tsushima M (1979) Combined therapy of T3 and antidepressants in depression. J Int Med Res 7:138-146.
98. van Marwijk HWJ, Bekker FM, Nolen WA, Jansen PAF, van Nieuwkerk JF, Hop WCJ (1990) Lithium augmentation in geriatric depression. J Affect Disord 20:217-223.
99. Volz H-P, Müller H, Sturm Y, Preubler B, Moller H-J (1995) Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks. Psychiatry Res 58:107-115.
100. Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: A preliminary report. J Clin Psychiatry 50:447-449.
101. Zajecka JM, Jeffriess H, Fawcett J (1995) The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: A retrospective analysis. J Clin Psychiatry 56:338-343.
102. Zarate CA Jr, Kando JC, Tohen M, Weiss MK, Cole JO (1996) Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? J Clin Psychiatry 57:67-71.
103. Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF III (1991) Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 11:254-256.